H. Arnold

1.5k total citations
61 papers, 1.3k citations indexed

About

H. Arnold is a scholar working on Physiology, Molecular Biology and Surgery. According to data from OpenAlex, H. Arnold has authored 61 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Physiology, 14 papers in Molecular Biology and 13 papers in Surgery. Recurrent topics in H. Arnold's work include Erythrocyte Function and Pathophysiology (24 papers), Neonatal Health and Biochemistry (11 papers) and Pancreatic function and diabetes (10 papers). H. Arnold is often cited by papers focused on Erythrocyte Function and Pathophysiology (24 papers), Neonatal Health and Biochemistry (11 papers) and Pancreatic function and diabetes (10 papers). H. Arnold collaborates with scholars based in Germany, United States and Switzerland. H. Arnold's co-authors include Dirk Pette, G. W. Löhr, Roland Henning, K. G. Blume, Karl G. Blume, D. Büsch, Ernest Beutler, Rupert Engelhardt, H. Henß and Klaus Maier and has published in prestigious journals such as Blood, FEBS Letters and European Journal of Biochemistry.

In The Last Decade

H. Arnold

59 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Arnold Germany 17 513 463 410 222 217 61 1.3k
Kathryn M. John United States 18 1.2k 2.3× 816 1.8× 449 1.1× 314 1.4× 140 0.6× 22 2.2k
Adrien R. Beaudoin Canada 20 724 1.4× 235 0.5× 147 0.4× 349 1.6× 133 0.6× 45 1.9k
T. E. Ukena United States 18 1.0k 2.0× 267 0.6× 311 0.8× 150 0.7× 41 0.2× 27 1.7k
M J A Tanner United Kingdom 29 1.3k 2.5× 1.4k 3.1× 356 0.9× 227 1.0× 351 1.6× 47 2.6k
Ulrich Salzer Austria 18 791 1.5× 547 1.2× 443 1.1× 99 0.4× 76 0.4× 34 1.4k
Shigenori Ogata Japan 21 772 1.5× 184 0.4× 376 0.9× 167 0.8× 64 0.3× 45 1.4k
Matthias Gautschi Switzerland 21 1.1k 2.2× 289 0.6× 289 0.7× 107 0.5× 77 0.4× 55 1.8k
Mitsushi Inomata Japan 28 1.2k 2.3× 298 0.6× 903 2.2× 91 0.4× 26 0.1× 55 1.9k
Mutsumi Inaba Japan 18 381 0.7× 431 0.9× 117 0.3× 124 0.6× 96 0.4× 71 968
Marie‐Christine Lecomte France 22 662 1.3× 894 1.9× 344 0.8× 168 0.8× 204 0.9× 61 1.6k

Countries citing papers authored by H. Arnold

Since Specialization
Citations

This map shows the geographic impact of H. Arnold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Arnold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Arnold more than expected).

Fields of papers citing papers by H. Arnold

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Arnold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Arnold. The network helps show where H. Arnold may publish in the future.

Co-authorship network of co-authors of H. Arnold

This figure shows the co-authorship network connecting the top 25 collaborators of H. Arnold. A scholar is included among the top collaborators of H. Arnold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Arnold. H. Arnold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kay, Laurence, Małgorzata Tokarska-Schlattner, Peter Bugert, et al.. (2017). Creatine kinase in human erythrocytes: A genetic anomaly reveals presence of soluble brain-type isoform. Blood Cells Molecules and Diseases. 64. 33–37. 1 indexed citations
2.
Burkhardt, Claus, et al.. (2014). Design study of a Miniaturized Displacement Transducer (MDT) for an active middle ear implant system. Biomedical Microdevices. 16(6). 805–814. 6 indexed citations
3.
Arnold, H., et al.. (2006). Objektivierung der Muskelregeneration durch Messung der Kraft des Musculus abductor pollicis brevis nach Karpaldachspaltung. Handchirurgie · Mikrochirurgie · Plastische Chirurgie. 38(5). 296–299. 3 indexed citations
4.
Steinke, B., H.-M. Reinold, Manfred Heim, et al.. (1992). Cyclic alternating chemotherapy of high-grade malignant non-Hodgkin lymphomas with VIM-Bleo and CHOP. European Journal of Cancer. 28(1). 100–104. 5 indexed citations
5.
Dietl, J., et al.. (1989). Effect of cesarean section on outcome in high- and low-risk very preterm infants. Archives of Gynecology and Obstetrics. 246(2). 91–96. 5 indexed citations
6.
Henß, H., et al.. (1988). Phase-II Study with the Combination of Cisplatin and Doxorubicin in Advanced Malignant Mesothelioma of the Pleura. Oncology Research and Treatment. 11(3). 118–120. 24 indexed citations
7.
Steinke, B., et al.. (1988). Response-oriented therapy with CHOP and VIM-Bleo in high-grade malignant non-Hodgkin's lymphomas. Annals of Hematology. 56(6). 269–271. 4 indexed citations
8.
Flechtner, Hans‐Henning, W. Queißer, Manfred Heim, et al.. (1987). 5-Fluorouracil, 4-Epidoxorubicin, and Mitomycin C (FEM) Combination Chemotherapy for Advanced Gastric Carcinoma. A Phase-II Trial by the “Chemotherapiegruppe Gastrointestinaler Tumoren (CGT)”. Oncology Research and Treatment. 10(2). 67–71. 5 indexed citations
9.
Queißer, W., Helmut König, Dieter Fritze, et al.. (1986). Phase III study of 5-FU and carmustine versus 5-FU, carmustine, and doxorubicin in advanced gastric cancer.. PubMed. 70(4). 477–9. 19 indexed citations
10.
Fiebig, H.H., W Wellens, M. Peukert, et al.. (1984). Phase-II-Studie des wasserlöslichen Nitrosoharnstoffes ACNU bei fortgeschrittenen kolorektalen Karzinomen. Oncology Research and Treatment. 7(6). 370–377. 3 indexed citations
11.
12.
Arnold, H., et al.. (1983). Glucosephosphate-isomerase type kaiserslautern. Annals of Hematology. 46(5). 271–277. 3 indexed citations
13.
Andreesen, Reinhard, H. Arnold, & G. W. L�hr. (1982). Cytotoxic activity in the serum of a patient with metastasizing nephroblastoma given intravenous infusions of alkyl-lysophospholipids in a phase I study. Annals of Hematology. 44(2). 79–82. 1 indexed citations
14.
Arnold, H., et al.. (1980). Augsburg-type glucosephosphate isomerase deficiency. Annals of Hematology. 40(2). 107–115. 4 indexed citations
15.
Arnold, H.. (1979). Inherited glucosephosphate isomerase deficiency. Annals of Hematology. 39(6). 405–417. 15 indexed citations
16.
Arnold, H., et al.. (1978). Creatine kinase in human erythrocytes: A newly detected genetic anomaly. Annals of Hematology. 37(5). 249–256. 9 indexed citations
17.
Arnold, H., et al.. (1977). Glucosephosphate isomerase deficiency type Li�ge: A new variant with congenital nonspherocytic hemolytic anemia. Annals of Hematology. 35(3). 187–193. 5 indexed citations
18.
Löhr, G. W., H. Arnold, Karl G. Blume, Rupert Engelhardt, & Ernst Beutler. (1973). Hereditary deficiency of glucosephosphate isomerase as a cause of nonspherocytic hemolytic anemia. Annals of Hematology. 26(6). 393–398. 16 indexed citations
19.
Arnold, H. & Klaus Maier. (1971). Crystallization and some properties of glutamate dehydrogenase from rat liver. Biochimica et Biophysica Acta (BBA) - Protein Structure. 251(2). 133–140. 19 indexed citations
20.
Arnold, H., et al.. (1952). [The system dye salt-carbinol base of crystal violet in vitro and vivo. Pharmacotherapy of oxyuriasis. IV].. PubMed. 2(5). 224–31. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kathryn M. John Breakdown of academic impact, for papers by Adrien R. Beaudoin Breakdown of academic impact, for papers by T. E. Ukena Breakdown of academic impact, for papers by M J A Tanner Breakdown of academic impact, for papers by Ulrich Salzer Breakdown of academic impact, for papers by Shigenori Ogata Breakdown of academic impact, for papers by Matthias Gautschi Breakdown of academic impact, for papers by Mitsushi Inomata Breakdown of academic impact, for papers by Mutsumi Inaba Breakdown of academic impact, for papers by Marie‐Christine Lecomte
Rankless by CCL
2026